Please ensure Javascript is enabled for purposes of website accessibility
Moderna Asking Regulators to OK Its Virus Shots
gvw_ap_news
By Associated Press
Published 5 years ago on
November 30, 2020

Share

Moderna Inc. said it would ask U.S. and European regulators Monday to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection — ramping up the race to begin limited vaccinations as the coronavirus rampage worsens.

Multiple vaccine candidates must succeed for the world to stamp out the pandemic, which has been on the upswing in the U.S. and Europe. U.S. hospitals have been stretched to the limit as the nation has seen more than 160,000 new cases per day and more than 1,400 daily deaths. Since first emerging nearly a year ago in China, the virus has killed more than 1.4 million people worldwide.

Moderna is just behind Pfizer and its German partner BioNTech in seeking to begin vaccinations in the U.S. in December. British regulators also are assessing the Pfizer shot and another from AstraZeneca.

Moderna created its shots with the U.S. National Institutes of Health and already had a hint they were working, but said it got the final needed results over the weekend that suggest the vaccine is more than 94% effective.

Of 196 COVID-19 cases so far in its huge U.S. study, 185 were trial participants who received the placebo and 11 who got the real vaccine. The only people who got severely ill — 30 participants, including one who died — had received dummy shots, said Dr. Tal Zaks, the Cambridge, Massachusetts, company’s chief medical officer.

When he learned the results, “I allowed myself to cry for the first time,” Zaks told The Associated Press. “We have already, just in the trial, have already saved lives. Just imagine the impact then multiplied to the people who can get this vaccine.”

Moderna said the shots’ effectiveness and a good safety record so far — with only temporary, flu-like side effects — mean they meet requirements set by the U.S. Food and Drug Administration for emergency use before the final-stage testing is complete. The European Medicines Agency, Europe’s version of FDA, has signaled it also is open to faster “conditional” clearance.

What Comes Next

The FDA has pledged that before it decides to roll out any COVID-19 vaccines, its scientific advisers will publicly debate whether there’s enough evidence behind each candidate.

First up on Dec. 10, Pfizer and BioNTech will present data suggesting their vaccine candidate is 95% effective. Moderna said its turn at this “science court” is expected exactly a week later, on Dec. 17.

Rationing Initial Doses

If the FDA allows emergency use, Moderna expects to have 20 million doses ready for the U.S. by year’s end. Recipients will need two doses, so that’s enough for 10 million people.

Pfizer expects to have 50 million doses globally in December. Half of them — or enough for 12.5 million people — are earmarked for the U.S.

Shipments are set to begin to states within 24 hours of FDA clearance. And this week, a different panel of U.S. experts, established by the Centers for Disease Control and Prevention, will meet to decide how those initial supplies will be given out. They’re expected to reserve scarce first doses for health care workers and, if the shots work well enough in the frail elderly, for residents of long-term care facilities.

As more vaccine gradually becomes available in coming months, other essential workers and people at highest risk from the coronavirus would get in line. But enough for the general U.S. population isn’t expected until at least spring.

Outside the U.S., Zaks said significant supplies from Moderna would be available later, “in the first quarter” of next year.

“Obviously we are doing everything in our power to increase the capacity and accelerate the timelines,” he said.

Britain’s government said Sunday it has ordered 7 million doses from Moderna.

The U.K. also has ordered 40 million doses of the Pfizer-BioNTech vaccine, although it’s not clear how much of the companies’ limited December supply could go toward that order — if British health authorities clear the shots. Still, British hospitals are gearing up to receive some doses as early as next week.

Both Moderna’s and Pfizer’s vaccines are made with the same technology, using a piece of genetic code for the “spike” protein that studs the virus. That messenger RNA, or mRNA, instructs the body to make some harmless spike protein, training immune cells to recognize it if the real virus eventually comes along.

AstraZeneca Confusion

AstraZeneca and Oxford University last week announced confusing early results of their vaccine candidate from research in Britain and Brazil.

That vaccine appears 62% effective when tested as originally intended, with recipients given two full doses. But because of a manufacturing error, a small number of volunteers got a lower first dose — and AstraZeneca said in that group, the vaccine appeared to be 90% effective.

Experts say it’s unclear why the lower-dose approach would work better and that it may just be a statistical quirk.

A larger U.S. study of the AstraZeneca candidate still is underway that should eventually give the FDA a better picture of how well it works. The FDA has said any COVID-19 vaccine would have to be at least 50% effective.

Meanwhile Britain’s government will have to decide whether its U.K. data is sufficient for an early rollout there.

Still in the Pipeline

Johnson & Johnson also is in final-stage testing in the U.S. and several other countries to see if its vaccine candidate could work with just one dose.

Both the J&J and AstraZeneca vaccines work by using harmless cold viruses to carry the spike protein gene into the body and prime the immune system.

The different technologies have ramifications for how easily different vaccines could be distributed globally. The AstraZeneca shots won’t require freezer storage like the Pfizer and Moderna vaccines.

Candidates made with still other technologies are in late-stage testing, too. Another U.S. company, Novavax Inc., announced Monday that it has finished enrolling 15,000 people in a late-stage study in Britain and plans to begin recruiting even more volunteers for final testing in the U.S. and Mexico “in the coming weeks.”

Vaccines made by three Chinese companies and a Russian candidate also are being tested in thousands of people in countries around the world.

RELATED TOPICS:

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

4 Million Acres of California Forests Could Lose Protection. What Trump’s ‘Roadless Rule’ Repeal Could Do

DON'T MISS

Israeli Settlers Raid West Bank Town, Troops Kill 3 Palestinians

DON'T MISS

West Nile Virus Detected in Mosquitoes in Fresno County

DON'T MISS

Trump Says Netanyahu’s Trial Should Be Canceled

DON'T MISS

St. Agnes’ New Chief Medical Officer Is a Kidney Care Expert

DON'T MISS

US Military to Create Two New Border Zones, Officials Say

DON'T MISS

Trump Signals US May Ease Iran Oil Sanction Enforcement to Help Rebuild Country

DON'T MISS

CIA Says Intelligence Indicates Iran’s Nuclear Program Severely Damaged

DON'T MISS

Upscale Woodward Park Area Apartments Sell for $19 Million

DON'T MISS

Wired Wednesday: Learn the Latest on the Caleb Quick Murder Hearings

UP NEXT

Cuomo Concedes to Mamdani in New York City Democratic Mayoral Contest

UP NEXT

Mamdani Holds Lead Over Cuomo in Democratic Primary for NYC Mayor

UP NEXT

Clovis Man Sentenced to 8 Years in Federal Prison in Deadly Fentanyl Case

UP NEXT

Victims Identified as Death Toll Climbs to 8 in Lake Tahoe Boating Tragedy

UP NEXT

Florida to Build ‘Alligator Alcatraz’ Detention Center for Migrants in Everglades

UP NEXT

Americans Worry Conflict With Iran Could Escalate, Reuters/Ipsos Poll Finds

UP NEXT

Advisory Warns of ‘Heightened Threat Environment’ in US After Iran Strikes

UP NEXT

Amazon’s Prime Day 2025 Levels Up With Four Days of Deals Starting July 8

UP NEXT

Voice of America Parent Terminates Over 600 More Staff in Likely Death Knell

UP NEXT

US Court Lets Trump Keep Control of California National Guard for Now

Trump Says Netanyahu’s Trial Should Be Canceled

14 hours ago

St. Agnes’ New Chief Medical Officer Is a Kidney Care Expert

14 hours ago

US Military to Create Two New Border Zones, Officials Say

15 hours ago

Trump Signals US May Ease Iran Oil Sanction Enforcement to Help Rebuild Country

15 hours ago

CIA Says Intelligence Indicates Iran’s Nuclear Program Severely Damaged

16 hours ago

Upscale Woodward Park Area Apartments Sell for $19 Million

17 hours ago

Wired Wednesday: Learn the Latest on the Caleb Quick Murder Hearings

17 hours ago

Trump Administration Orders CA to Strip Trans Athlete of Medals

18 hours ago

Three Mile Island Nuclear Plant Reboot Fast-Tracked to 2027

18 hours ago

Democratic Lawmaker Pleads Not Guilty to Assaulting US Agents at Immigration Center

18 hours ago

4 Million Acres of California Forests Could Lose Protection. What Trump’s ‘Roadless Rule’ Repeal Could Do

This story was originally published by CalMatters. Sign up for their newsletters. The Trump administration’s plan to repeal a rule prohibiti...

14 hours ago

Tahoe National Forest
14 hours ago

4 Million Acres of California Forests Could Lose Protection. What Trump’s ‘Roadless Rule’ Repeal Could Do

Palestinians gather to receive aid supplies in Beit Lahia, in the northern Gaza Strip, June 17, 2025. REUTERS/Stringer/File Photo
14 hours ago

Israeli Settlers Raid West Bank Town, Troops Kill 3 Palestinians

West Nile virus mosquito
14 hours ago

West Nile Virus Detected in Mosquitoes in Fresno County

President Donald Trump meets with Israeli Prime Minister Benjamin Netanyahu in the Oval Office at the White House in Washington, U.S., April 7, 2025. (Reuters File)
14 hours ago

Trump Says Netanyahu’s Trial Should Be Canceled

14 hours ago

St. Agnes’ New Chief Medical Officer Is a Kidney Care Expert

A U.S. Border Patrol vehicle patrols along the border wall, following the establishment of a 260-mile military zone along the southern U.S. border in New Mexico and Texas as part of the Trump administration's crackdown on immigration, in Sunland Park, New Mexico, U.S., May 20, 2025. (Reuters File)
15 hours ago

US Military to Create Two New Border Zones, Officials Say

Oil tankers pass through the Strait of Hormuz, December 21, 2018. (Reuters File)
15 hours ago

Trump Signals US May Ease Iran Oil Sanction Enforcement to Help Rebuild Country

CIA Director John Ratcliffe speaks during an interview at the White House in Washington, D.C., U.S., April 30, 2025. (Reuters File)
16 hours ago

CIA Says Intelligence Indicates Iran’s Nuclear Program Severely Damaged

Help continue the work that gets you the news that matters most.

Search

Send this to a friend